The role of interferon‐γ, nitric oxide and lipopolysaccharide in intestinal graft‐versus‐host disease developing in F1‐hybrid mice
暂无分享,去创建一个
[1] D. Thiele,et al. TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J→C57BL/6J × bm12)F1 Mice1 , 2002, The Journal of Immunology.
[2] J. Gartner,et al. GVHD‐Associated Enteropathy and Endotoxemia in F1‐Hybrid Recipients of NK1.1‐Depleted Grafts , 2001, Scandinavian journal of immunology.
[3] D. Nance,et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. , 2000, Cancer research.
[4] A. Moran,et al. Cytotoxicity associated with induction of nitric oxide synthase in rat duodenal epithelial cells in vivo by lipopolysaccharide of Helicobacter pylori: inhibition by superoxide dismutase , 2000, British journal of pharmacology.
[5] P. Neuhaus,et al. Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis. , 2000, Transplantation.
[6] E. Crouser,et al. Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. , 2000, American journal of respiratory and critical care medicine.
[7] U. Fölsch,et al. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor α and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy , 1999, Gut.
[8] A. Elmaagacli,et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospect , 1999, Blood.
[9] B. Beutler,et al. Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. , 1999, Gastroenterology.
[10] K. HayGlass,et al. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. , 1998, Journal of immunology.
[11] J. Crawford,et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.
[12] F. P. Nestel,et al. Progressive Accumulation of Bacterial Lipopolysaccharide In Vivo During Murine Acute Graft‐Versus‐Host Disease , 1997, Scandinavian journal of immunology.
[13] H. Ford,et al. Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. , 1997, Transplantation.
[14] W. Koltun,et al. Increased intestinal permeability in rats with graft versus host disease. , 1996, Gut.
[15] C. Bogdan,et al. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. , 1995, European journal of pharmacology.
[16] M. Currie,et al. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. , 1994, Journal of Medicinal Chemistry.
[17] R. Gress,et al. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. , 1994, Journal of immunology.
[18] W. Wilmanns,et al. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. , 1993, Transplantation proceedings.
[19] U. Graeven,et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. , 1992, Blood.
[20] F. Liew,et al. Nitric oxide mediates intestinal pathology in graft‐vs.‐host disease , 1992, European journal of immunology.
[21] F. P. Nestel,et al. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease , 1992, The Journal of experimental medicine.
[22] A. Mowat,et al. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. , 1989, Immunology.
[23] P. Vassalli,et al. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[24] J. Gartner,et al. AN ANALYSIS OF PULMONARY NATURAL KILLER CELL ACTIVITY IN F1‐HYBRID MICE WITH ACUTE GRAFT‐TERSUS-HOST REACTIONS , 1988, Transplantation.
[25] P. Vassalli,et al. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease , 1987, The Journal of experimental medicine.
[26] T. Ghayur,et al. The Functional and Histological Basis for Graft‐versus‐Host‐Induced Immunosuppression , 1985, Immunological reviews.
[27] J. L. Rosenberg,et al. Small intestinal injury in the immunologically runted mouse. Morphologic and autoradiographic studies. , 1971, The Journal of laboratory and clinical medicine.
[28] J. Jones,et al. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. , 1971, Radiation research.
[29] R. Blaese,et al. IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS. , 1964 .
[30] R. Blaese,et al. IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS , 1964, The Journal of experimental medicine.
[31] M. Woodruff,et al. Effect of the graft-versus-host reaction on the immunological responsiveness of the mouse , 1961, Proceedings of the Royal Society of London. Series B. Biological Sciences.